Imperial College London
Portrait Picture

DrKevinMonahan

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

k.monahan Website

 
 
//

Location

 

CRUKSt Marks HospitalNorthwick Park and St Marks Site

//

Summary

 

Publications

Citation

BibTex format

@article{Monahan:2022:10.1136/gutjnl-2022-327985,
author = {Monahan, KJ and Davies, MM and Abulafi, M and Banerjea, A and Nicholson, BD and Arasaradnam, R and Barker, N and Benton, S and Booth, R and Burling, D and Carten, RV and D'Souza, N and East, JE and Kleijnen, J and Machesney, M and Pettman, M and Pipe, J and Saker, L and Sharp, L and Stephenson, J and Steele, RJC},
doi = {10.1136/gutjnl-2022-327985},
journal = {Gut},
pages = {1939--1962},
title = {Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)},
url = {http://dx.doi.org/10.1136/gutjnl-2022-327985},
volume = {71},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Faecal immunochemical testing (FIT) has a high sensitivity for the detection of colorectal cancer (CRC). In a symptomatic population FIT may identify those patients who require colorectal investigation with the highest priority. FIT offers considerable advantages over the use of symptoms alone, as an objective measure of risk with a vastly superior positive predictive value for CRC, while conversely identifying a truly low risk cohort of patients. The aim of this guideline was to provide a clear strategy for the use of FIT in the diagnostic pathway of people with signs or symptoms of a suspected diagnosis of CRC. The guideline was jointly developed by the Association of Coloproctology of Great Britain and Ireland/British Society of Gastroenterology, specifically by a 21-member multidisciplinary guideline development group (GDG). A systematic review of 13 535 publications was undertaken to develop 23 evidence and expert opinion-based recommendations for the triage of people with symptoms of a suspected CRC diagnosis in primary care. In order to achieve consensus among a broad group of key stakeholders, we completed an extended Delphi of the GDG, and also 61 other individuals across the UK and Ireland, including by members of the public, charities and primary and secondary care. Seventeen research recommendations were also prioritised to inform clinical management.
AU  - Monahan,KJ
AU  - Davies,MM
AU  - Abulafi,M
AU  - Banerjea,A
AU  - Nicholson,BD
AU  - Arasaradnam,R
AU  - Barker,N
AU  - Benton,S
AU  - Booth,R
AU  - Burling,D
AU  - Carten,RV
AU  - D'Souza,N
AU  - East,JE
AU  - Kleijnen,J
AU  - Machesney,M
AU  - Pettman,M
AU  - Pipe,J
AU  - Saker,L
AU  - Sharp,L
AU  - Stephenson,J
AU  - Steele,RJC
DO  - 10.1136/gutjnl-2022-327985
EP  - 1962
PY  - 2022///
SN  - 0017-5749
SP  - 1939
TI  - Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)
T2  - Gut
UR  - http://dx.doi.org/10.1136/gutjnl-2022-327985
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000824422100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://gut.bmj.com/content/71/10/1939
UR  - http://hdl.handle.net/10044/1/100510
VL  - 71
ER  -
Download